Her2/ErbB2
Catalog Number:OM638908
Product Profile
Product Name
Her2/ErbB2
Antibody Type
Primary Antibodies
Immunogen
peptide
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WB ICC IHC FC
WB :1:500~1:2000ICC :1:200~1:500IHC :1:50~1:200FC :1:200~1:500Notes :Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
Human
Concentration
1 mg/mL.
Target Information
Alternative Names
Verb b2 erythroblastic leukemia viral oncogene homolog 2 neuro/glioblastoma derived oncogene homolog antibody
C erb B2/neu protein antibody
CD340 antibody
CD340 antigen antibody
Cerb B2/neu protein antibody
CerbB2 antibody
Erb b2 receptor tyrosine kinase 2 antibody
ERBB2 antibody
ERBB2_HUMAN antibody
HER 2 antibody
HER 2/NEU antibody
HER2 antibody
Herstatin antibody
Human epidermal growth factor receptor 2 antibody
Metastatic lymph node gene 19 protein antibody
MLN 19 antibody
MLN19 antibody
NEU antibody
NEU proto oncogene antibody
Neuro/glioblastoma derived oncogene homolog antibody
Neuroblastoma/glioblastoma derived oncogene homolog antibody
NGL antibody
p185erbB2 antibody
Proto-oncogene c-ErbB-2 antibody
Proto-oncogene Neu antibody
Receptor tyrosine-protein kinase erbB-2 antibody
TKR1 antibody
Tyrosine kinase type cell surface receptor HER2 antibody
Tyrosine kinase-type cell surface receptor HER2 antibody
V erb b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) antibody
V erb b2 avian erythroblastic leukemia viral oncogene homolog 2 antibody
V erb b2 avian erythroblastic leukemia viral oncoprotein 2 antibody
V erb b2 erythroblastic leukemia viral oncogene homolog 2 neuro/glioblastoma derived oncogene homolog (avian) antibody
V erb b2 erythroblastic leukemia viral oncogene homolog 2 neuro/glioblastoma derived oncogene homolog antibody
Verb b2 erythroblastic leukemia viral oncogene homolog 2 neuro/glioblastoma derived oncogene homolog (avian) antibody
Database Links
Application
Application Notes
WB :1:500~1:2000ICC :1:200~1:500IHC :1:50~1:200FC :1:200~1:500Notes :Optimal dilutions/concentrations should be determined by the researcher.
Additional Information
Form
Liquid
Storage Instructions
Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
Storage Buffer
1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.
Catalog Number:
OM638908
Price:
$ 336.00
Discount Price
Size:
100 μl
Store:
Out of stock
Lead time:
4~6 Week
Quantity:
-
+
Shipping to (Please select)
Afghanistan
Albania
Algeria
Andorra
Angola
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Brazil
Brunei
Bulgaria
Cambodia
Cameroon
Canada
Cape Verde
Central African Republic
Chad
Chile
China
Comoros
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Ecuador
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia, The
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, South
Kuwait
Latvia
Lebanon
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Morocco
Mozambique
Myanmar
Nepa
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saint Kitts and Nevis
Samoa
Sao Tome and Principe
Senegal
Seychelles
Singapore
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
The Republic of Colombia
Togo
Tonga
Tunisia
Turkey
Tuvalu
Uganda
Ukraine
United Kingdom
United States
Uruguay
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
Contact our distributors
Afghanistan
Albania
Algeria
Andorra
Angola
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Brazil
Brunei
Bulgaria
Cambodia
Cameroon
Canada
Cape Verde
Central African Republic
Chad
Chile
China
Comoros
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Ecuador
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia, The
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, South
Kuwait
Latvia
Lebanon
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Morocco
Mozambique
Myanmar
Nepa
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saint Kitts and Nevis
Samoa
Sao Tome and Principe
Senegal
Seychelles
Singapore
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
The Republic of Colombia
Togo
Tonga
Tunisia
Turkey
Tuvalu
Uganda
Ukraine
United Kingdom
United States
Uruguay
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe